Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Melbourne
Clinical trial register · Australia

Clinical Trials in Melbourne, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3379 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:18 UTC
3379
Studies in scope
all four open statuses
1825
Recruiting now
open to new participants
783
Lead sponsors
across recruiting studies
Top sites
Melbourne 15 Blacktown 14 Concord 13 Clayton 13 Nedlands 13

Trials with a site in Melbourne

15 of 3379 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
BeOne Medicines
Phase 3
1,056
Blacktown, Liverpool, Wollongong, Birtinya, Douglas, Melbourne, Murdoch, Nedlands
2026-05-22
Recruiting
BeOne Medicines
Phase 3
500
Blacktown, Concord, St Leonards, Woolloongabba, Clayton, Heidelberg, Malvern, Melbourne
2026-01-22
Recruiting
BeOne Medicines
Phase 1
186
Blacktown, Camperdown, Adelaide, Heidelberg, Melbourne
2025-12-11
Recruiting
BeOne Medicines
Phase 1
105
Blacktown, St Leonards, Auchenflower, Malvern, Melbourne, Nedlands
2025-12-11
Recruiting
BeOne Medicines
Phase 1
63
Blacktown, Adelaide, Clayton, Melbourne
2025-11-10
Recruiting
BeOne Medicines
Phase 1
120
Darlinghurst, Waratah, Birtinya, Melbourne, St Albans, Nedlands
2025-02-04
Recruiting
BeOne Medicines
Phase 1/2
258
Blacktown, Adelaide, Malvern, Melbourne, Cooloongup, Nedlands
2025-01-23
Recruiting
BeOne Medicines
Phase 1/2
80
Kogarah, South Brisbane, Clayton, Melbourne, Nedlands
2024-11-27
Recruiting
BeOne Medicines
Phase 1
310
Blacktown, Frenchs Forest, Birtinya, Adelaide, Melbourne, Nedlands
2024-10-03
Recruiting
BeOne Medicines
Phase 1
308
Blacktown, North Ryde, Wollongong, Woolloongabba, Clayton, Malvern, Melbourne, Nedlands
2024-04-12
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
NCT06120283Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer, Hormone-receptor-positive Breast Cancer
BeOne Medicines
Phase 1
433
Blacktown, Bowral, Concord, North Ryde, Douglas, Adelaide, Heidelberg, Melbourne
2023-12-01
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines
Phase 1/2
689
Concord, Waratah, Woolloongabba, Fitzroy, Heidelberg, Melbourne, Nedlands, West Perth
2021-09-13
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
BeOne Medicines
Phase 1/2
260
Concord, Kogarah, Orange, Southport, Clayton, Fitzroy, Heidelberg, Melbourne
2021-05-24
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-australia/city/melbourne

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,379 studies in total at the last sync on 18 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Melbourne that also match the filters currently applied.

How many clinical trials are recruiting in Melbourne?

15 of the 15 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Melbourne), 15 studies
PhaseStudiesRecruitingShare
Phase 17746.7%
Phase 1/25533.3%
Phase 33320%

Most active sponsors

Lead sponsors with the most studies (Melbourne)
Lead sponsorStudiesRecruiting
BeOne Medicines1515
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.